Health Advocates Sound Alarm as RFK Jr.'s Controversial Leadership at HHS Sparks Outcry
Health advocates raised serious concerns when President Donald Trump first nominated Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS), citing his history of promoting vaccine skepticism and conspiracy theories. Now, even the conservative *Wall Street Journal* Editorial Board is criticizing the administration for allowing Kennedy to operate with little oversight.
In a recent editorial, the board noted that some Senate Republicans who confirmed Kennedy had hoped other Trump appointees—such as FDA Commissioner Marty Makary and NIH Director Jay Bhattacharya—would counterbalance his influence. However, the board warned, "It isn’t working out that way."
#Controversial CDC Appointment Raises Red Flags
One of the most troubling developments under Kennedy’s leadership is the potential hiring of David Geier, a longtime vaccine critic, as a "senior data analyst" for a new CDC study on vaccines and autism. While the White House has not confirmed Geier’s involvement, his history of promoting debunked theories has alarmed experts.
Geier has spent years pushing the widely discredited claim—also championed by Kennedy—that thimerosal in vaccines causes autism and neurological damage in children. Despite his numerous studies being dismissed by courts and government vaccine tribunals, trial lawyers have cited his work in lawsuits against vaccine manufacturers. Geier has also accused the CDC of hiding safety data and falsely claimed that improved nutrition and hygiene—not vaccines—are responsible for the decline of deadly infectious diseases.
The *WSJ* Editorial Board warned that if Geier is involved in the CDC study, "the study’s results look preordained," suggesting a biased outcome that could undermine public trust in vaccines.
#Brain Drain at HHS as Top Scientists Depart
Another major concern is the potential exodus of experienced scientists and medical professionals who oppose Kennedy’s anti-vaccine agenda. The board highlighted the resignation of Dr. Peter Marks, a key figure in President Trump’s Operation Warp Speed, which accelerated the development of COVID-19 vaccines.
Marks, who also advocated for faster approval of life-saving treatments for children with rare genetic disorders, stepped down last week. In his resignation letter, he wrote, *"It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies."*
The board expressed dismay over Marks’ departure, noting his efforts to push back against bureaucratic delays at the FDA—even clashing with Biden-era FDA Commissioner Robert Califf over drug approval standards. His exit, they argued, signals a dangerous trend of sidelining science in favor of ideology.
#"Our Worst Fears Are Coming True"
The *WSJ* Editorial Board concluded with a stark warning: *"Our worst fears about Mr. Kennedy are coming true."* His leadership, they argued, threatens to erode public confidence in vital health institutions, promote misinformation, and drive away top scientific talent.
As Kennedy continues to push controversial policies and personnel decisions, the fallout could have lasting consequences for public health—raising urgent questions about the administration’s commitment to evidence-based medicine.
Comments
Post a Comment